The FDA recently approved a new device from Medtronic that turns a smartphone into a patient’s pacemaker monitor that can send stats to their doctor in real time. The MyCareLink Smart Monitor is able ...
On February 20, 2024, Medtronic MDT Corporation (NYSE: MDT, $85.90, Market Capitalization: $114.2 billion) in its 3Q24 earnings call announced that it no longer plans to spin-off its Patient ...
Medtronic Inc. said Monday that a continuous glucose monitoring system recently received European regulatory approval. The Fridley-based medical technology giant said the Sentrino system -- the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback